Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

Article  PubMed  Google Scholar 

Schwartz SR, Yueh B, Maynard C, Daley J, Henderson W, Khuri SF (2004) Predictors of wound complications after laryngectomy A study of over 2000 patients. Otolaryngol-head neck surg. 131(1):61–68

Article  PubMed  Google Scholar 

RyanP G, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC et al (2017) Complications, hospital length of stay, and readmission after total laryngectomy. Cancer 123(10):1760–1767

Article  Google Scholar 

Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690

Article  PubMed  Google Scholar 

Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol 23(10):2708–2714

Article  PubMed  PubMed Central  Google Scholar 

Knochelmann HM, Horton JD, Liu S, Armeson K, Kaczmar JM, Wyatt MM et al (2021) Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Reports Medicine 2(10):100426

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, De Castro G et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. The Lancet 394(10212):1915–1928

Article  CAS  Google Scholar 

Mandal R, Şenbabaoğlu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, et al (2016) The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight [Internet]. 2016 Oct 20 [cited 2023 Dec 21];1(17). Available from: https://insight.jci.org/articles/view/89829

Chen S, Yang Y, Wang R, Fang J (2023) Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis. Oral Oncol 145:106479

Article  CAS  PubMed  Google Scholar 

Schwartz LH, Litière S, De Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1–Update and clarification: From the RECIST committee. Eur J Cancer 62:132–137

Article  PubMed  PubMed Central  Google Scholar 

Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Rad Oncol Biol Phys. 31(5):1341–1346

Article  CAS  Google Scholar 

Yang YF, Wang R, Fang JG, Zhong Q, Huang ZG, Chen XH et al (2020) A single-arm prospective study on induction chemotherapy and subsequent comprehensive therapy for advanced hypopharyngeal squamous cell carcinoma: report of 260 cases in a single center. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 55(12):1143–1153

CAS  PubMed  Google Scholar 

Ma J, Liu Y, Yang X, Zhang C ping, Zhang Z yuan, Zhong L ping (2013) Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis. World J Surg Onc. 11(1):67

Vermorken JB, Remenar E, Van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. N Engl J Med 357(17):1695–1704

Article  CAS  PubMed  Google Scholar 

Merchant YP, Mehta V, Aaqib Shamim M, Shah A, Shetty R (2023) Cost-benefit analysis of immune checkpoint inhibitors: Is the price worth their value? Oral Oncol 146:106560

Article  CAS  PubMed  Google Scholar 

Wu WJ, Liu Q, An PG, Wang L, Zhang JY, Chen Y et al (2023) Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study. Front Immunol 14(14):1282629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wahida A, Buschhorn L, Fröhling S, Jost PJ, Schneeweiss A, Lichter P et al (2023) The coming decade in precision oncology: six riddles. Nat Rev Cancer 23(1):43–54

Article  CAS  PubMed  Google Scholar 

Mariniello A, Nasti TH, Chang DY, Hashimoto M, Malik S, McManus DT, et al (2023) Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade. Clin Cancer Res OF1–13